# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000896264-24-000093
Filing Date
2024-02-27
Accepted
2024-02-27 16:26:50
Documents
100
Period of Report
2023-12-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | usna-20231230.htm iXBRL | 10-K | 1819409
2 | EX-21 | subsidiaries-exhibit21.htm | EX-21 | 21866
3 | EX-23.1 | usna-20231230xexhibit231.htm | EX-23.1 | 1983
4 | EX-31.1 | usna-20231230xex311.htm | EX-31.1 | 9998
5 | EX-31.2 | usna-20231230xex312.htm | EX-31.2 | 10031
6 | EX-32.1 | usna-20231230xex321.htm | EX-32.1 | 3981
7 | EX-32.2 | usna-20231230xex322.htm | EX-32.2 | 4064
8 | EX-97 | ex-97usanaxclawbackpolicy.htm | EX-97 | 17313
14 | CUMULITIVE SHAREHOLDER RETURN | usna-20231230_g1.jpg | GRAPHIC | 130333
| Complete submission text file | 0000896264-24-000093.txt |  | 9936961

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | usna-20231230.xsd | EX-101.SCH | 65995
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | usna-20231230_cal.xml | EX-101.CAL | 106306
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | usna-20231230_def.xml | EX-101.DEF | 275491
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | usna-20231230_lab.xml | EX-101.LAB | 867586
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | usna-20231230_pre.xml | EX-101.PRE | 553412
102 | EXTRACTED XBRL INSTANCE DOCUMENT | usna-20231230_htm.xml | XML | 1446968

Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1230
Type: 10-K | Act: 34 | File No.: 001-35024 | Film No.: 24687257
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)